Furthermore, in both pre- and postmenopausal TNBC, we noted that SERF1A, a gene with no known function and part of a gene signature used to estimate the likelihood of BC recurrence [17], was upregulated in the CC genotype (p-value = 0.0004 and 0.0083, respectively). This evidence concerns the gene SERF1A and breast cancer.